Assembly Biosciences (ASMB) Depreciation & Amortization (CF) (2018 - 2026)
Assembly Biosciences (ASMB) posted quarterly Depreciation & Amortization (CF) of $26000.0 for Q1 2026, down 21.21% year-over-year from $33000.0 in Q1 2025, and down 18.75% quarter-over-quarter from $32000.0 in Q4 2025.
Powered by 
Analysis
Assembly Biosciences (ASMB) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends
Assembly Biosciences' Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $26000.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 21.21% year-over-year to $26000.0; the TTM figure through Mar 2026 stood at $122000.0 (down 6.15% YoY), while the FY2025 annual figure was $129000.0, changed 0.0% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $26000.0, down from $32000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $134000.0 in Q3 2022, with the low at $26000.0 in Q1 2026.
- The 5-year median for Depreciation & Amortization (CF) is $33000.0 (2024), against an average of $72470.6.
- The sharpest annual moves came in 2022 and 2024: Depreciation & Amortization (CF) grew 12.61% in 2022, then plunged 74.6% in 2024.
- Assembly Biosciences' Depreciation & Amortization (CF) stood at $124000.0 in 2022, then sank by 32.26% to $84000.0 in 2023, then plunged by 61.9% to $32000.0 in 2024, then changed by 0.0% to $32000.0 in 2025, then fell by 18.75% to $26000.0 in 2026.
- Business Quant data shows ASMB's Depreciation & Amortization (CF) at $26000.0 in Q1 2026, $32000.0 in Q4 2025, and $32000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 40.52 Mn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | - |
| 10 | Assembly Biosciences | 683.92 Mn | 363.56 Mn | - | 20,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20,000.00 |
| Mar 31, 2026 | 26,000.00 |
| Dec 31, 2025 | 32,000.00 |
| Sep 30, 2025 | 32,000.00 |
| Jun 30, 2025 | 32,000.00 |
| Mar 31, 2025 | 33,000.00 |
| Dec 31, 2024 | 32,000.00 |
| Sep 30, 2024 | 33,000.00 |
| Jun 30, 2024 | 32,000.00 |
| Mar 31, 2024 | 32,000.00 |
| Dec 31, 2023 | 84,000.00 |
| Sep 30, 2023 | 116,000.00 |
| Jun 30, 2023 | 126,000.00 |
| Mar 31, 2023 | 124,000.00 |
| Dec 31, 2022 | 124,000.00 |
| Sep 30, 2022 | 134,000.00 |
| Jun 30, 2022 | 120,000.00 |
| Mar 31, 2022 | 120,000.00 |
| Dec 31, 2021 | 120,000.00 |
| Sep 30, 2021 | 119,000.00 |